Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.
about
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protectionOver-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovaniAntimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune responseOver-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovaniDuplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenUse of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.Optimizing efficacy of Amphotericin B through nanomodification.Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos.Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.An Evaluation of Quantitative PCR Assays (TaqMan® and SYBR Green) for the Detection of Babesia bigemina and Babesia bovis, and a Novel Fluorescent-ITS1-PCR Capillary Electrophoresis Method for Genotyping B. bovis Isolates.Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster.Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
P2860
Q27304818-5F46C434-D9BD-4357-A625-8E32E22EC6F2Q28536134-4CFA91E7-6D00-497D-BFD7-923B2D0D60BAQ28540810-CBF98C6F-D3B0-4543-B1D1-089A004E7535Q28547415-9ED2B0F3-1015-41A1-B67A-1DD0E23A102BQ33612946-DBA83379-8D40-42DC-AFE3-B95211F04619Q34637852-9477000B-84DA-4E25-B526-4446E490D8B5Q36482804-23787B84-9195-4E58-80D5-3C7678D0AC01Q37178176-F13A7D93-F49D-4365-A5B7-C1884AFE12A4Q38154629-92752C8B-09DB-4548-903B-6EC2B8DA0694Q39505379-4D31FBA2-B9E2-4952-8951-67FC5B39817DQ43378666-1E77BD34-9000-41C2-BC68-58C7701FB993Q44606808-7D7B6A20-4538-4EA3-94F5-C0641F5AFCBDQ51747317-12C2DBA2-7266-4044-A8EC-CF3E6512D8A1
P2860
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@en
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@nl
type
label
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@en
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@nl
prefLabel
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@en
Real-time reverse transcriptio ...... ew amphotericin B formulation.
@nl
P2093
P2860
P50
P1476
Real-time reverse transcriptio ...... new amphotericin B formulation
@en
P2093
J A Sanchez-Brunete
M A Dea-Ayuela
S Rama Iñiguez
P2860
P304
P356
10.1128/AAC.50.4.1195-1201.2006
P407
P577
2006-04-01T00:00:00Z